Determining therapeutic susceptibility in multiple myeloma by single-cell mass accumulation

Multiple myeloma (MM) has benefited from significant advancements in treatment that have improved outcomes and reduced morbidity. However, the disease remains incurable and is characterized by high rates of drug resistance and relapse. Consequently, methods to select the most efficacious therapy are...

Descripción completa

Detalles Bibliográficos
Autores principales: Cetin, Arif E., Stevens, Mark M., Calistri, Nicholas L., Fulciniti, Mariateresa, Olcum, Selim, Kimmerling, Robert J., Munshi, Nikhil C., Manalis, Scott R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5694762/
https://www.ncbi.nlm.nih.gov/pubmed/29151572
http://dx.doi.org/10.1038/s41467-017-01593-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5694762/
https://www.ncbi.nlm.nih.gov/pubmed/29151572
http://dx.doi.org/10.1038/s41467-017-01593-2

Ejemplares similares